Cargando…

IL-6 inhibition in the treatment of COVID-19: A meta-analysis and meta-regression

OBJECTIVES: Multiple RCTs of interleukin-6 (IL-6) inhibitors in COVID-19 have been published, with conflicting conclusions. We performed a meta-analysis to assess the impact of IL-6 inhibition on mortality from COVID-19, utilising meta-regression to explore differences in study results. METHODS: Sys...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tharmarajah, Emmanuel, Buazon, April, Patel, Vishit, Hannah, Jennifer R., Adas, Maryam, Allen, Victoria B., Bechman, Katie, Clarke, Benjamin D., Nagra, Deepak, Norton, Sam, Russell, Mark D., Rutherford, Andrew I., Yates, Mark, Galloway, James B.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The British Infection Association. Published by Elsevier Ltd. 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7970418/ https://www.ncbi.nlm.nih.gov/pubmed/33745918 http://dx.doi.org/10.1016/j.jinf.2021.03.008

Ejemplares similares

A systematic review and network meta-analysis of the safety of early interventional treatments in rheumatoid arthritis
por: Adas, Maryam A, et al.
Publicado: (2021)

A Systematic Review and Meta-Analysis of Anti-Rheumatic Drugs and Pneumococcal Vaccine Immunogenicity in Inflammatory Arthritis
por: Nagra, Deepak, et al.
Publicado: (2023)

The safety of JAK-1 inhibitors
por: Clarke, Benjamin, et al.
Publicado: (2021)

A Kawasaki-like illness in an adult with recent SARS-CoV-2 infection
por: Nagra, Deepak, et al.
Publicado: (2021)

JAK inhibitors and the risk of malignancy: a meta-analysis across disease indications
por: Russell, Mark D, et al.
Publicado: (2023)

EP18 Testicular sarcoidosis: a challenging diagnosis
por: Patel, Vishit, et al.
Publicado: (2020)

OA12 Grimey granulomas of sarcoidosis
por: Nagra, Deepak, et al.
Publicado: (2023)

EP21 Tumour necrosis factor inhibitor for the treatment of refractory extra-pulmonary disease including sarcoid arthritis and myositis
por: Rampes, Sanketh, et al.
Publicado: (2020)

Diagnostic delay is common for patients with axial spondyloarthritis: results from the National Early Inflammatory Arthritis Audit
por: Russell, Mark D, et al.
Publicado: (2021)

Corrigendum to: Diagnostic delay is common for patients with axial spondyloarthritis: results from the National Early Inflammatory Arthritis Audit
por: Russell, Mark D, et al.
Publicado: (2021)

COVID-19: opacification score is higher in the right lung and right lung involvement is a better predictor of ICU admission
por: Nagra, Deepak, et al.
Publicado: (2020)

The new entries in the therapeutic armamentarium: The small molecule JAK inhibitors
por: Bechman, Katie, et al.
Publicado: (2019)

Corrigendum to “The new entries in the therapeutic armamentarium: The small molecule JAK inhibitors” [Pharmacol. Res. 147 (2019) 104392]
por: Bechman, Katie, et al.
Publicado: (2020)

Is background methotrexate advantageous in extending TNF inhibitor drug survival in elderly patients with rheumatoid arthritis? An analysis of the British Society for Rheumatology Biologics Register
por: Bechman, Katie, et al.
Publicado: (2020)

Corrigendum to: Is background methotrexate advantageous in extending TNF inhibitor drug survival in elderly patients with rheumatoid arthritis? An analysis of the British Society for Rheumatology Biologics Register
por: Bechman, Katie, et al.
Publicado: (2020)

Inpatient COVID-19 mortality has reduced over time: Results from an observational cohort
por: Bechman, Katie, et al.
Publicado: (2022)

Data quality predicts care quality: findings from a national clinical audit
por: Yates, Mark, et al.
Publicado: (2020)

High numbers of COVID-19 patients transit through non-COVID wards, and associated healthcare workers have high infection rates: An observational cross-sectional study
por: Nallamilli, Susanna, et al.
Publicado: (2022)

The infection risks of JAK inhibition
por: Adas, Maryam A., et al.
Publicado: (2021)

P15 JAKi of all trades
por: Watkins, Clara, et al.
Publicado: (2023)

Incidence and management of inflammatory arthritis in England before and during the COVID-19 pandemic: a population-level cohort study using OpenSAFELY
por: Russell, Mark D, et al.
Publicado: (2022)

Changing trends in ethnicity and academic performance: observational cohort data from a UK medical school
por: Mukherji, Prokriti, et al.
Publicado: (2022)

Disease activity and its predictors in early inflammatory arthritis: findings from a national cohort
por: Yates, Mark, et al.
Publicado: (2021)

Real-world evidence for prehospital COVID-19 treatment in systemic autoimmune rheumatic disease
por: Bechman, Katie, et al.
Publicado: (2023)

Diagnosing Camurati–Engelmann disease—the age of whole-exome sequencing
por: Nagra, Deepak, et al.
Publicado: (2022)

EP13 A case of candida albicans septic sacroiliitis complicating severe COVID-19 infection
por: Onac, Ioana, et al.
Publicado: (2020)

Mental health, fatigue and function are associated with increased risk of disease flare following TNF inhibitor tapering in patients with rheumatoid arthritis: an exploratory analysis of data from the Optimizing TNF Tapering in RA (OPTTIRA) trial
por: Bechman, Katie, et al.
Publicado: (2018)

The immunosuppressed traveler: infection risks with autoimmunity and immunosuppression, vaccinations, and general travel advice
por: Allen, Victoria, et al.
Publicado: (2020)

COVID-19 admissions and mortality in patients with early inflammatory arthritis: results from a UK national cohort
por: Adas, Maryam A, et al.
Publicado: (2023)

Management of gout following 2016/2017 European (EULAR) and British (BSR) guidelines: An interrupted time-series analysis in the United Kingdom
por: Russell, Mark D, et al.
Publicado: (2022)

Treat-to-target urate-lowering therapy and hospitalizations for gout: results from a nationwide cohort study in England
por: Russell, Mark D, et al.
Publicado: (2022)

Worse outcomes linked to ethnicity for early inflammatory arthritis in England and Wales: a national cohort study
por: Adas, Maryam A, et al.
Publicado: (2022)

A systematic review of CXCL13 as a biomarker of disease and treatment response in rheumatoid arthritis
por: Bechman, Katie, et al.
Publicado: (2020)

A refined method for multivariate meta-analysis and meta-regression
por: Jackson, Daniel, et al.
Publicado: (2014)

Exploring the macro-level, meso-level and micro-level barriers and facilitators to the provision of good quality early inflammatory arthritis (EIA) care in England and Wales
por: Zasada, Magdalena, et al.
Publicado: (2021)

A clinical risk score to identify patients with COVID-19 at high risk of critical care admission or death: An observational cohort study
por: Galloway, James B, et al.
Publicado: (2020)

IL-6 and IL-10 as predictors of disease severity in COVID-19 patients: results from meta-analysis and regression
por: Dhar, Sujan K., et al.
Publicado: (2021)

Improving outcomes for patients hospitalized with gout: a systematic review
por: Russell, Mark D, et al.
Publicado: (2021)

Meta‐analysis and meta‐regression of transcriptomic responses to water stress in Arabidopsis
por: Rest, Joshua S., et al.
Publicado: (2016)

The efficacy of immune checkpoint inhibitors in elderly patients: a meta-analysis and meta-regression
por: Kim, C.M., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_2b46f12up6d8dj3vuirnmo7csq